Effect of immunomodulatory therapies on mortality in adults hospitalised with COVID-19 and non-COVID-19 community-acquired pneumonia: A systematic review and meta-analysis.
BACKGROUND Community-acquired pneumonia (CAP) is the leading infectious cause of morbidity and mortality globally. Severe disease is driven by a dysregulated host inflammatory response, leading to tissue damage. Despite numerous immunomodulatory strategies studied in CAP, their effectiveness remains unclear. OBJECTIV...